Nuveen Asset Management’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.39M | Buy |
171,978
+1,679
| +1% | +$13.6K | ﹤0.01% | 2544 |
|
|
2024
Q3 | $1.38M | Hold |
170,299
| – | – | ﹤0.01% | 2611 |
|
|
2024
Q2 | $737K | Buy |
170,299
+20,619
| +14% | +$89.3K | ﹤0.01% | 2853 |
|
|
2024
Q1 | $635K | Sell |
149,680
-91,801
| -38% | -$389K | ﹤0.01% | 2890 |
|
|
2023
Q4 | $908K | Buy |
241,481
+84,656
| +54% | +$318K | ﹤0.01% | 2778 |
|
|
2023
Q3 | $580K | Sell |
156,825
-40,210
| -20% | -$149K | ﹤0.01% | 2796 |
|
|
2023
Q2 | $781K | Buy |
+197,035
| New | +$781K | ﹤0.01% | 2755 |
|
|
2022
Q2 | – | Sell |
-177,925
| Closed | -$880K | – | 3268 |
|
|
2022
Q1 | $880K | Buy |
177,925
+1,329
| +0.8% | +$6.57K | ﹤0.01% | 2853 |
|
|
2021
Q4 | $850K | Sell |
176,596
-23,054
| -12% | -$111K | ﹤0.01% | 2908 |
|
|
2021
Q3 | $932K | Sell |
199,650
-26,815
| -12% | -$125K | ﹤0.01% | 3008 |
|
|
2021
Q2 | $1.55M | Buy |
226,465
+29,241
| +15% | +$201K | ﹤0.01% | 2818 |
|
|
2021
Q1 | $1.97M | Sell |
197,224
-16,741
| -8% | -$167K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $1.59M | Buy |
213,965
+80,257
| +60% | +$596K | ﹤0.01% | 2622 |
|
|
2020
Q3 | $806K | Buy |
133,708
+11,792
| +10% | +$71.1K | ﹤0.01% | 2778 |
|
|
2020
Q2 | $768K | Sell |
121,916
-66,009
| -35% | -$416K | ﹤0.01% | 2734 |
|
|
2020
Q1 | $675K | Buy |
187,925
+26,326
| +16% | +$94.6K | ﹤0.01% | 2661 |
|
|
2019
Q4 | $1.18M | Buy |
161,599
+100,158
| +163% | +$729K | ﹤0.01% | 2626 |
|
|
2019
Q3 | $392K | Sell |
61,441
-105,100
| -63% | -$671K | ﹤0.01% | 3007 |
|
|
2019
Q2 | $1.49M | Buy |
+166,541
| New | +$1.49M | ﹤0.01% | 2568 |
|